![Chemical structure of 2-[(2,3-Dimethylphenyl)amino]benzoic acid, CAS 61-68-7](https://api.angenesci.com/structure/247/61-68-7.png)
No data
No data
No data
| CAS Number | 61-68-7 |
| Catalog Number | AG0039LC(AGN-PC-0WADMZ) |
| Chemical Name | 2-[(2,3-Dimethylphenyl)amino]benzoic acid |
| EC Number | 200-513-1 |
| IUPAC Name | 2-(2,3-dimethylanilino)benzoic acid |
| InChI | InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18) |
| InChI Key | HYYBABOKPJLUIN-UHFFFAOYSA-N |
| MDL Number | MFCD00051721 |
| Molecular Formula | C15H15NO2 |
| Molecular Weight | 241.2851 |
| SMILES | CC1=C(C=CC=C1C)NC1=C(C(=O)O)C=CC=C1 |
| UNII | 367589PJ2C |
| Synonyms | Acid, Mefenamic,
Apo Mefenamic,
Apo-Mefenamic,
Contraflam,
Coslan,
Dysman,
Mefac,
Mefacit,
Mefenamic Acid,
Mefenaminic Acid,
Mefic,
Nu Mefenamic,
Nu-Mefenamic,
Parkemed,
Pinalgesic,
PMS Mefenamic Acid,
PMS-Mefenamic Acid,
Ponalar,
Ponalgic,
Ponmel,
Ponstan,
Ponstan Forte,
Ponstel,
Ponsyl,
Pontal,
mefenamic acid,
61-68-7,
Ponstel,
2-[(2,3-dimethylphenyl)amino]benzoic acid,
Ponstan,
Mephenamic acid,
Parkemed,
Coslan,
Mefacit,
Ponalar,
Methenamic acid,
Mephenaminic acid,
Bonabol,
Lysalgo,
Tanston,
Vialidon,
2-((2,3-Dimethylphenyl)amino)benzoic acid,
Bafameritin-M,
Tamany Bonsan,
Acide mefenamique,
Mefenaminsaeure,
Ponstan forte,
Namphen,
Pontal,
Mefanamic acid,
Bafhameritin-M,
CN-35355,
Mefenacid,
Ponstil,
Ponstyl,
Acido mefenamico,
Acidum mefenamicum,
HL 1,
N-(2,3-Xylyl)anthranilic acid,
Mefedolo,
Mycasaal,
N-2,3-Xylylanthranilic acid,
Rolan,
INF 3355,
INF-3355,
N-(2,3-Dimethylphenyl)anthranilic acid,
AGN-1255,
CI-473,
CL 473,
2-(2,3-Dimethylanilino)benzoic acid,
N-(2,3-Xylyl)-2-aminobenzoic acid,
Mefenaminsaeure [German],
Ac. mefenamico [Italian],
in-M,
Acide mefenamique [French],
Benzoic acid, 2-[(2,3-dimethylphenyl)amino]-,
Acide mefenamique [INN-French],
Acido mefenamico [INN-Spanish],
Acidum mefenamicum [INN-Latin],
Anthranilic acid, N-2,3-xylyl-,
CN 35355,
NSC 94437,
2-(2,3-dimethylphenylamino)benzoic acid,
UNII-367589PJ2C,
HSDB 3115,
EINECS 200-513-1,
Anthranilic acid, N-(2,3-xylyl)-,
Benzoic acid, 2-((2,3-dimethylphenyl)amino)-,
CI 473,
MFCD00051721,
2-Diphenylaminecarboxylic acid, 2',3'-dimethyl-,
CHEMBL686,
BRN 2216243,
MLS000069709,
CHEBI:6717,
HYYBABOKPJLUIN-UHFFFAOYSA-N,
NSC94437,
367589PJ2C,
CAS-61-68-7,
NCGC00016278-07,
CPD000058188,
SMR000058188,
Benzoic acid, 2-(2,3-dimethylphenyl)amino-,
DSSTox_CID_3243,
DSSTox_RID_76938,
DSSTox_GSID_23243,
Mefenamicacid,
2-(2,3-Xylidino)benzoic Acid,
SR-01000000216,
Mefenaminsaure,
mefenamic-acid,
Ponstel, Ponstan,
Prestwick_506,
Mefenamic Acid,(S),
Spectrum_000174,
Opera_ID_542,
Mefenamic acid [USAN:USP:INN:BAN:JAN],
AC1L1HAE,
AC1Q2NNQ,
Prestwick0_000054,
Prestwick1_000054,
Prestwick2_000054,
Prestwick3_000054,
Spectrum2_001941,
Spectrum3_001082,
Spectrum4_001235,
Spectrum5_001341,
M1782,
Anthranilic acid,3-xylyl-,
cid_4044,
SCHEMBL3544,
Oprea1_193889,
BSPBio_000207,
BSPBio_002724,
KBioGR_001730,
KBioSS_000654,
MLS001074162,
DivK1c_000298,
SPECTRUM1501103,
SPBio_002001,
SPBio_002128,
BPBio1_000229,
F0850-6853,
GTPL2593,
SGCUT00005,
WLN: QVR BMR B1 C1,
DTXSID5023243,
HMS500O20,
KBio1_000298,
KBio2_000654,
KBio2_003222,
KBio2_005790,
KBio3_001944,
KS-00000WDA,
ZINC20241,
BRD8217,
NINDS_000298,
CI 473 pound notCN-35355,
HMS1568K09,
HMS1921D13,
HMS2090B07,
HMS2092B17,
HMS2095K09,
HMS2232P18,
HMS3259M19,
HMS3370K18,
HMS3652A10,
HMS3712K09,
Pharmakon1600-01501103,
Mefenamic acid (JP17/USP/INN),
Mefenamic acid, analytical standard,
ALBB-025759,
BCP08499,
BRD-8217,
HY-B0574,
to_000071,
Tox21_110344,
Tox21_301983,
BBL003564,
BDBM50134036,
CCG-39434,
NSC-94437,
NSC757834,
s4078,
SBB056999,
STK666691,
AKOS001025551,
AKOS002388313,
Benzoic acid,3-dimethylphenyl)amino]-,
Tox21_110344_1,
CS-2681,
DB00784,
MCULE-1031776135,
NC00517,
NSC-757834,
IDI1_000298,
SMP2_000141,
2-(2,3-Dimethylanilino)benzoic acid #,
NCGC00016278-01,
NCGC00016278-02,
NCGC00016278-03,
NCGC00016278-04,
NCGC00016278-05,
NCGC00016278-06,
NCGC00016278-10,
NCGC00022393-03,
NCGC00022393-04,
NCGC00022393-05,
NCGC00255401-01,
AC-11160,
AJ-08418,
AK-72920,
AN-23714,
AS-12677,
BC201828,
BR-72920,
LS-20589,
SAM002554908,
SC-16204,
ST086740,
SBI-0051636.P002,
2-(2,3-Dimethyl-phenylamino)-benzoic acid,
AB0012318,
AB1009470,
ST2409237,
2-[(2,3-dimethylphenyl) amino]benzoic acid,
2-Diphenylaminecarboxylic acid,3'-dimethyl-,
AB00052200,
AM20060688,
FT-0628184,
SW196700-3,
UNM000001233403,
C02168,
D00151,
M-6454,
AB00052200-17,
AB00052200_18,
AB00052200_19,
A833367,
I14-3644,
SR-01000000216-2,
SR-01000000216-4,
W-105113,
BRD-K92778217-001-06-1,
Z56755828,
2-(2,3-Dimethyl-phenylamino)-benzoic acid(Mefenamic acid),
A1077/0050549,
Mefenamic acid, European Pharmacopoeia (EP) Reference Standard,
Mefenamic acid, United States Pharmacopeia (USP) Reference Standard,
4-methyl-N-(3-{3-[(4-methylpiperidin-1-yl)carbonyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)benzenesulfonamide,
InChI=1/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18,
Mefenamate,
Fenamin,
Mefenaminic Acid,
Ac. mefenamico,
Contraflam,
Pinalgesic,
Ponalgic,
Dysman,
Ponmel,
Ponsyl,
Mefac,
Mefic,
Apo Mefenamic,
Apo-Mefenamic,
Nu Mefenamic,
Nu-Mefenamic,
Acid, Mefenamic,
ApoMefenamic,
NuMefenamic,
mefenamsyre-,
Forte, Ponstan,
Ponstel (TN),
PMS Mefenamic Acid,
PMS-Mefenamic Acid,
Acid, Mefenaminic,
Mephadolor (TN),
Dyfenamic (TN),
Mafepain (TN),
Parkemed (TN),
Potarlon (TN),
Ponstal (TN),
Ponstan (TN),
Meftal (TN),
D05FTJ,
C15H15NO2,
APS Brand of Mefenamic Acid,
Elan Brand of Mefenamic Acid,
Rowa Brand of Mefenamic Acid,
Apotex Brand of Mefenamic Acid,
Pfizer Brand of Mefenamic Acid,
Mefenamic acid [USAN:INN:BAN:JAN],
Antigen Brand of Mefenamic Acid,
Clonmel Brand of Mefenamic Acid,
Godecke Brand of Mefenamic Acid,
Chemidex Brand of Mefenamic Acid,
Pinewood Brand of Mefenamic Acid,
CID4044,
Ashbourne Brand of Mefenamic Acid,
Nu Pharm Brand of Mefenamic Acid,
Nu-Pharm Brand of Mefenamic Acid,
Mefenamic acid (JP15/USP/INN),
Farmasierra Brand of Mefenamic Acid,
Parke Davis Brand of Mefenamic Acid,
C15-H15-N-O2,
Pharmascience Brand of Mefenamic Acid,
First Horizon Brand of Mefenamic Acid,
Mefenamic acid [USAN:BAN:INN:JAN],
CS-O-11682,
Warner Lambert Brand of Mefenamic Acid,
Warner-Lambert Brand of Mefenamic Acid,
Mefenamic acid, 98% - 100G 100g,
B1449,
1-Benzyl-3-methylimidazolium tetrafluoroborate,
1-Methyl-3-benzylimidazolium tetrafluoroborate,
D008528,
ID8,
500996-04-3,
|
| Complexity | 292 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 241.11g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 18 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 241.29g/mol |
| Monoisotopic Mass | 241.11g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 49.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 5.1 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

